# 神经科技设备市场

> 神经技术设备市场研究报告按应用（神经外科、神经调节、认知增强、神经康复、脑-机接口）、按设备类型（侵入性设备、非侵入性设备、植入式设备、可穿戴设备）、按最终用户（医院、研究机构、居家护理、康复中心）、按技术（脑电图、功能性磁共振成像、经颅磁刺激、深脑刺激）以及按地区（北美、欧洲、南美、亚太、中东和非洲）- 预测到2035年

- **Forecast Period:** 2025 - 2035
- **CAGR:** 11.25%
- **2024:** $ 13.27 Billion
- **2025:** $ 14.77 Billion
- **2035:** $ 42.89 Billion
- **Key Players:** NeuroPace (US), Medtronic(US), Boston Scientific (US), Abbott (US), Nervana (US), Blackrock Neurotech (US), Synchron (US), NeuroSky (US), Ceregate (DE)

**Report ID:** MRFR/HC/32084-HCR · **Pages:** 100 · **Author:** Rahul Gotadki · **Last Updated:** September 17, 2026

**URL:** https://www.marketresearchfuture.com/reports/neurotech-device-market-33922

---

## Market Summary

## **Neurotechnology Device Market Overview**

As per MRFR analysis, the Neurotech Device Market Size was estimated at 13.27 (USD Billion) in 2024. The Neurotech Device Market Industry is expected to grow from 14.77 (USD Billion) in 2025 to 38.55 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 11.25% during the forecast period (2025 - 2034).

### **Key Neurotechnology Device Market Trends Highlighted**

The global neurotechnology device market is experiencing significant growth driven by the increasing prevalence of neurological disorders, rising awareness of mental health issues, and advancements in neuroengineering technologies.

The demand for effective treatment options and diagnostic tools has led to innovations such as brain-computer interfaces and neurostimulation devices. Moreover, the growing investment in research and development by both public and private sectors is further propelling market expansion.

There are numerous opportunities to be captured within this market, particularly in areas like personalized medicine and remote monitoring solutions.

As technology improves, there is potential for integrating neurotechnology with artificial intelligence, enhancing the efficacy of devices used for therapeutic purposes. Emerging markets also present a unique chance for expansion as healthcare systems worldwide seek to address the increasing burden of neurological conditions.

Trends in recent times include the increasing use of wearable neurotechnology devices that allow for continuous monitoring and real-time data collection. This has led to a shift in focus from conventional treatment methods to more proactive approaches to managing neurological health.

Additionally, there is a rising interest in neurotechnology applications within areas such as cognitive enhancement and neurofeedback therapy, reflecting a broader acceptance of these solutions in everyday life.

The convergence of neuroscience, technology, and healthcare is creating a dynamic environment ripe for innovation, promising long-term benefits for patients and healthcare providers alike. As the market evolves, it will be crucial to address regulatory challenges and ensure the ethical application of these advanced technologies to foster trust and acceptance among users.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **Neurotechnology Device Market Drivers**

### **Rising Prevalence of Neurological Disorders**

One of the foremost drivers influencing the growth of the global neurotechnology device market is the escalating prevalence of neurological disorders across the globe. Conditions such as epilepsy, Parkinson's disease, Alzheimer's disease, and traumatic brain injuries are becoming increasingly common, affected by aging populations and lifestyle changes.

This rise in incidence necessitates enhanced diagnostic and therapeutic solutions, thereby fostering significant demand for neurotechnology devices.

As the medical community pushes toward better treatment methodologies, the use of neurostimulation devices and diagnostic tools becomes crucial. Furthermore, the urgency for effective management of these disorders drives innovation within the industry, promoting the development of advanced technologies such as brain-computer interfaces, deep brain stimulation, and neuroimaging devices.

These technologies not only aim to improve patient outcomes but also open new avenues for research, hence increasing investments and collaborations among various stakeholders in the global neurotechnology device market.

As more institutions undertake studies that require neurotechnological insights, the cumulative impact on market expansion becomes pronounced, reflecting in the rapidly evolving landscape of neurological treatments tailored to meet growing patient needs.

This continuous rise in demand is anticipated to create a robust market environment for neurotechnology devices in the upcoming years.

### **Technological Advancements in Neurotechnology**

Technological advancements play a significant role in driving the global neurotechnology device market forward. Remarkable innovations such as miniaturized and highly efficient neurostimulation systems, brain-computer interfaces, and enhanced neuroimaging techniques have improved both treatment efficacy and patient accessibility.

For instance, portable devices allowing remote monitoring of neurological conditions empower patients and healthcare professionals alike.

These advancements not only enhance clinical outcomes but also decrease the cost of management. As technology evolves, new opportunities for novel applications in neurology arise, opening pathways for research and development that were unachievable earlier.

The continuous integration of artificial intelligence and machine learning into neurotechnology also fosters enhanced precision in diagnostics and treatment personalization.

### **Growing Investment and Funding in Neurotechnology Research**

The surge in investment and funding directed towards neurotechnology research significantly propels the global neurotechnology device market. With an increasing number of public and private entities recognizing the necessity for innovations in neurotechnology, financial support is vital for fostering groundbreaking research and driving product development.

Venture capitalists and governmental organizations are channeling resources into startups and research institutes focused on neurotechnology, aiming to prop up the advancement of new devices and solutions. As a result, many budding companies are emerging, contributing to a competitive landscape that incentivizes innovation and accelerates market expansion.

## **Neurotechnology Device Market Segment Insights**

### **Neurotechnology Device Market Application Insights**

The application segment is crucial in addressing various neurological disorders and enhancing cognitive functioning.

In this sector, Neurosurgery, valued at 2.14 USD billion in 2023, is witnessing significant importance, particularly due to advancements in surgical techniques and technologies such as neurostimulation and robotic interventions that are improving patient outcomes.

The Neuromodulation application holds a valuation of 3.5 USD billion in 2023, which underscores its dominant position in the market, driven by the increasing prevalence of neurological disorders such as epilepsy, depression, and chronic pain conditions. It is significant as it enhances the quality of life through innovative treatments that modify neurological activity.

Cognitive Enhancement was reflected with a market value of 1.8 USD billion in 2023, marking its emerging role as individuals seek to improve mental performance for academic and occupational success. Neurorehabilitation was another vital aspect, currently valued at 2.1 USD billion, and reflects notable growth opportunities through technologies that facilitate recovery post-stroke and brain injuries.

Finally, the Brain-Computer Interface segment, valued at 1.18 USD billion, showcased burgeoning interest as it provides methods for direct communication between the brain and external devices, which is significant for individuals with mobility impairments.

Each application contributes uniquely to the overall market growth, with Neurosurgery and Neuromodulation together capturing the majority holding of the overall market.

As the global neurotechnology device market evolves, these application segments present numerous growth opportunities driven by innovative technological advancements, changing healthcare needs, and rising investments in neurotechnology research.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **Neurotechnology Device Market Device Type Insights**

The global neurotechnology device market is poised for substantial growth, driven by advancements in both Invasive and Non-Invasive Devices.

Invasive Devices play a crucial role in advanced medical procedures, offering high accuracy and efficacy in treatment protocols, while Non-Invasive Devices are increasingly popular for their ease of use and patient comfort, leading to a broader market appeal. Implantable Devices serve critical functions in long-term monitoring and therapeutic applications, showcasing their importance in chronic conditions.

[Wearable Tracking Devices](../../../reports/wearable-tracking-devices-market-902) are revolutionizing patient care by enabling real-time health tracking and encouraging preventive measures. As the global neurotechnology device market segmentation continues to evolve, these device types create pathways for innovation, with a growing focus on enhancing patient outcomes and expanding access to neurotechnology solutions.

The market growth is also supported by rising investments in research and development, along with increasing awareness of neurological disorders and their impacts. These trends underscore the significance and dynamic nature of the Device Type landscape within the broader global neurotechnology device market.

### **Neurotechnology Device Market End User Insights**

The market comprises multiple segments like Hospitals, Research Institutions, Home Care Settings, and Rehabilitation Centers. Hospitals play a crucial role as they utilize advanced neurotechnology devices for diagnosis and treatment, attracting a significant share of the market.

Research Institutions are vital for innovation and development, contributing to the evolution of neurotechnologies and increasing their applicability in clinical settings.

Home Care Settings have gained traction, offering convenience and personalized care, which enhances patient comfort and monitoring. Rehabilitation Centers are essential for patient recovery processes, leveraging neurotechnology to facilitate recovery from neurological disorders and injuries.

The overall demand driven by an aging population, rising prevalence of neurological conditions, and advancements in technology are propelling the market forward, ultimately leading to increased global neurotechnology device market revenue.

Overall, this diversified segmentation highlights the broad application and relevance of neurotechnology across multiple sectors, presenting significant growth drivers and opportunities within the industry.

### **Neurotechnology Device Market Technology Insights**

Among the technology landscape, key areas such as Electroencephalography (EEG) and Functional Magnetic Resonance Imaging (fMRI) play crucial roles in brain activity monitoring and diagnostics.

Transcranial Magnetic Stimulation (TMS) has emerged as a significant non-invasive treatment modality, contributing to therapeutic interventions for various neurological disorders. Deep Brain Stimulation (DBS) is also remarkable in providing solutions for movement disorders and psychiatric conditions.

The advancements in these technologies are driven by the increasing prevalence of neurological disorders and rising awareness of neurotechnology's potential. The overall market growth can be attributed to the expanding applications of these devices in clinical settings and ongoing research into neural processes.

This technology segment exemplifies innovation and is set to dominate the global neurotechnology device market due to its essential role in both diagnostics and treatment strategies.

### **Neurotechnology Device Market Regional Insights**

The global neurotechnology device market exhibits substantial growth across various regions, with North America dominating the landscape, valued at 5.5 USD billion in 2023 and projected to reach 14.5 USD billion by 2032. This prominence is fueled by advanced healthcare infrastructure and significant investments in research and development.

Europe followed as the second largest market, reporting a value of 2.7 USD billion in 2023 and expected to grow to 7.0 USD billion by 2032, showcasing strong innovation in neurotechnology solutions. APAC was emerging steadily, with a valuation of 1.8 USD billion in 2023 and anticipated growth to 5.0 USD billion, driven by rising healthcare demands and technological advancements.

South America, while smaller at 0.5 USD billion in 2023, is projected to expand to 1.5 USD billion, presenting growth opportunities as awareness of neurotechnology increases. The Middle East and Africa (MEA) represented a nascent market with a value of 0.22 USD billion in 2023, expected to reach 0.8 USD billion, highlighting the potential for development in these regions.

Overall, the global neurotechnology device market revenue reflects a diverse landscape with unique regional dynamics and growth drivers.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **Neurotechnology Device Market Key Players and Competitive Insights**

The global neurotechnology device market is characterized by rapid technological advancements and innovations that are transforming the way neurological disorders and conditions are treated.

As a sector that encompasses a wide range of devices, from neurostimulation systems to brain-computer interfaces, the competitive landscape is marked by both established medical device manufacturers and emerging startups.

Market players are focusing on strategic partnerships, mergers, and acquisitions to enhance their product offerings and gain a significant share of the market. The increasing prevalence of neurological diseases and disorders, coupled with a growing awareness of neurotechnology among healthcare professionals, is driving the demand for devices that can provide effective and innovative solutions.

As a result, companies are continually investing in research and development to stay ahead of the competition and meet the needs of patients more efficiently.

Nervtech has established a strong presence within the global neurotechnology device market through its commitment to innovation and high-quality product development. The company specializes in advanced neurostimulation devices that address a variety of neurological conditions, positioning itself as a leader in this rapidly evolving sector.

With a solid research foundation, Nervtech is well-regarded for its robust clinical data, demonstrating the efficacy and safety of its devices. Additionally, the company's focus on user experience and patient engagement has contributed to its competitive advantage, ensuring that its products not only deliver therapeutic benefits but are also user-friendly and accessible.

This combination of technological prowess and commitment to patients' needs enables Nervtech to maintain a strong foothold in the market while attracting the attention of healthcare providers and patients alike.

Cynapsus Therapeutics operates with a clear focus on developing groundbreaking solutions within the global neurotechnology device market, specifically targeting conditions that affect cognition and mental well-being.

The company's innovative approach to neurotechnology is evident in its commitment to research-backed solutions that cater to patients suffering from neurological disorders. Cynapsus Therapeutics emphasizes the importance of explicit efficacy in its product portfolio, showcasing devices that aim to enhance cognitive functions and improve the quality of life for patients.

The organization actively collaborates with research institutions and clinicians, which enhances its market presence and strengthens its reputation as a reliable player in the neurotechnology landscape. Furthermore, Cynapsus Therapeutics' dedication to advancing the field through rigorous clinical trials and studies demonstrates its potential as a key contributor to the future of neurotechnology solutions.

### **Key Companies in the neurotechnology device market include**

- Nervtech
- Cynapsus Therapeutics
- Blackrock Neurotech
- Soterix Medical
- Boston Scientific
- Medtronic
- [Abbott Laboratories](https://www.abbott.com/life-changing-tech/parkinsons-deep-brain-stimulation-dbs-infinity.html)
- BrainCo
- Eko Devices
- Synchron
- Cerebrotech Medical Systems
- NeuroPace
- Harrow Health

## Neurotech Device Market Industry Developments

- **Q2 2024: Synchron Announces FDA Approval of First U.S. Clinical Trial for Brain-Computer Interface Implant** Synchron received FDA approval to begin the first U.S. clinical trial of its Stentrode brain-computer interface device, marking a significant regulatory milestone for neurotech implants.
- **Q2 2024: Neuralink raises $43 million in venture capital funding** Elon Musk's Neuralink raised $43 million in venture capital funding, according to a regulatory filing, to further develop its brain-computer interface technology.
- **Q2 2024: NeuroPace Announces FDA Approval of Next-Generation RNS System for Epilepsy** NeuroPace received FDA approval for its next-generation Responsive Neurostimulation (RNS) System, designed to treat drug-resistant epilepsy.
- **Q1 2024: Blackrock Neurotech Appoints Marcus Gerhardt as CEO** Blackrock Neurotech announced the appointment of Marcus Gerhardt as Chief Executive Officer, signaling a leadership change as the company advances its neurotechnology device portfolio.
- **Q2 2024: Bioinduction Announces Partnership with Medtronic to Advance Deep Brain Stimulation Therapies** Bioinduction entered a partnership with Medtronic to collaborate on the development and commercialization of next-generation deep brain stimulation devices.
- **Q1 2024: NeuroOne Receives FDA 510(k) Clearance for Evo sEEG Electrode** NeuroOne Medical Technologies received FDA 510(k) clearance for its Evo sEEG Electrode, expanding its portfolio of minimally invasive brain monitoring devices.
- **Q2 2024: Synchron Opens New Manufacturing Facility in California** Synchron announced the opening of a new manufacturing facility in California to scale up production of its brain-computer interface devices.
- **Q1 2024: Neuroelectrics Raises $17.5 Million Series B to Advance Non-Invasive Brain Stimulation** Neuroelectrics closed a $17.5 million Series B funding round to accelerate the development and commercialization of its non-invasive brain stimulation devices.
- **Q2 2024: Cala Health Announces FDA Clearance for Next-Generation Cala kIQ Device for Essential Tremor** Cala Health received FDA clearance for its next-generation Cala kIQ device, a wearable neurostimulation device for the treatment of essential tremor.
- **Q1 2024: NeuroSigma Announces Partnership with Otsuka to Commercialize Monarch eTNS System in Japan** NeuroSigma entered a partnership with Otsuka Pharmaceutical to commercialize the Monarch external trigeminal nerve stimulation (eTNS) system for ADHD in Japan.
- **Q2 2024: NeuroPace Announces $67 Million Financing to Support Commercial Expansion** NeuroPace secured $67 million in financing to support the commercial expansion of its neurostimulation devices for epilepsy treatment.
- **Q1 2024: Neurosoft Bioelectronics Raises $8 Million in Seed Funding to Develop Soft Brain Implants** Neurosoft Bioelectronics raised $8 million in seed funding to advance the development of its soft, flexible brain implants for neurological disorders.

## **Neurotechnology Device Market Segmentation Insights**

### **Neurotechnology Device Market Application Outlook**

- Neurosurgery
- Neuromodulation
- Cognitive Enhancement
- Neurorehabilitation
- Brain-Computer Interface

### **Neurotechnology Device Market Device Type Outlook**

- Invasive Devices
- Non-Invasive Devices
- Implantable Devices
- Wearable Devices

### **Neurotechnology Device Market End User Outlook**

- Hospitals
- Research Institutions
- Home Care Settings
- Rehabilitation Centers

### **Neurotechnology Device Market Technology Outlook**

- Electroencephalography
- Functional Magnetic Resonance Imaging
- Transcranial Magnetic Stimulation
- Deep Brain Stimulation

### **Neurotechnology Device Market Regional Outlook**

- North America
- Europe
- South America
- Asia Pacific
- Middle East and Africa

## Market Drivers

### 监管支持和框架

支持性监管框架的建立正在促进神经技术设备市场的增长。监管机构越来越认识到神经技术的潜力，并致力于制定促进创新的指导方针，同时确保安全性和有效性。这种积极的做法可能会鼓励制造商投资于新设备的开发，因为他们知道有明确的审批路径。随着法规的发展以适应神经技术所带来的独特挑战，市场预计将扩大，更多产品将进入市场。这种监管支持不仅增强了消费者信心，还刺激了竞争，最终使神经技术设备市场受益。

### 神经技术的技术进步

神经技术的快速进步，特别是在脑-计算机接口和神经刺激设备等领域，正在推动神经技术设备市场的发展。材料科学、信号处理和机器学习的创新使得开发更有效和用户友好的设备成为可能。例如，非侵入性神经刺激技术的引入扩展了神经技术的潜在应用，超越了传统的医疗用途。预计市场在未来几年将以超过12%的复合年增长率增长，反映出这些技术的日益普及。随着研究不断揭示新的可能性，神经技术设备市场可能会不断发展，为临床和消费者应用提供更好的解决方案。

### 神经系统疾病的发病率上升

神经系统疾病（如阿尔茨海默病、帕金森病和癫痫）的发病率不断上升，是神经技术设备市场的主要驱动力。根据最近的估计，受这些疾病影响的个体数量预计将显著增加，从而导致对创新神经技术解决方案的需求加大。这种流行率的激增需要先进的诊断和治疗设备，从而推动市场增长。神经技术设备市场预计将见证大量投资，旨在开发能够有效应对这些疾病的尖端技术。随着医疗系统努力改善患者的治疗效果，将神经技术设备整合到治疗方案中变得愈加重要，这表明该领域的未来前景广阔。

### 对神经科学研究的投资不断增长

神经科学研究资金的激增正在显著影响神经技术设备市场。各国政府和私人实体越来越认识到理解大脑功能及其对健康影响的重要性。这一投资的涌入正在促进创新神经技术设备的发展，旨在诊断和治疗各种神经系统疾病。近年来，神经科学研究的资金呈上升趋势，数十亿资金被分配给探索大脑健康和神经技术应用的项目。这一财政支持预计将催化神经技术设备市场的突破，导致新设备的推出，这些设备可能会改变患者护理并改善治疗结果。

### 提高对神经技术的认识和接受度

随着公众对神经技术的认识不断提高，其在医疗保健及其他领域的应用也越来越被接受。教育倡议和媒体报道在揭开神经技术的神秘面纱方面发挥了至关重要的作用，使消费者的知识水平得到了提升。这种观念的转变可能会推动对神经技术设备的需求，因为个人在健康管理方面变得更加愿意利用这些创新。神经技术设备市场有望从这一趋势中受益，因为接受度的提高可能会导致医疗服务提供者和患者的采用率上升。此外，随着更多成功案例的出现，市场可能会看到连锁反应，鼓励对神经技术解决方案的进一步投资和开发。

## Future Outlook

神经技术设备市场预计将在2024年至2035年间以11.25%的年复合增长率增长，推动因素包括技术进步、医疗保健投资增加以及对心理健康解决方案的需求上升。

**New opportunities:**

- 开发基于人工智能的神经反馈设备以实现个性化治疗。

到2035年，神经技术设备市场预计将实现显著增长和创新。

## Segment Insights

### 按应用：神经调节（最大）与脑-计算机接口（增长最快）

在神经技术设备市场中，各应用细分市场展现出多样的市场份额。神经调节已成为最大的细分市场，主要得益于其在治疗慢性疼痛和精神障碍方面的广泛临床应用。该细分市场涵盖了多种修改神经活动的设备，巩固了其在市场中的主导地位。相比之下，神经康复和认知增强细分市场也引起了相当大的关注，但其市场份额仍然相对较小，与神经调节和神经外科相比，后者因外科技术的进步而占据了重要地位。
神经技术设备市场的增长趋势表明，创新和技术进步正发生显著转变。脑-计算机接口（BCI）作为增长最快的细分市场之一，正获得越来越多的关注，这得益于对辅助设备的需求不断增加，这些设备能够帮助行动不便的个人进行沟通。此外，神经疾病的发病率上升以及对神经调节疗法有效性的认识不断提高，都是推动各应用细分市场增长的关键因素。因此，预计市场将继续经历动态增长，新兴技术将在塑造其未来方面发挥关键作用。

神经调节（主导）与认知增强（新兴）

神经调节在神经技术设备市场中占据主导地位，其特点是广泛应用于包括疼痛管理、抑郁症和癫痫等多种治疗领域。该领域的设备利用电刺激来调节神经回路，为患者提供非侵入性的解决方案，从而改善生活质量。相比之下，认知增强是一个新兴领域，专注于改善记忆和注意力等认知功能。由于对提升心理表现的兴趣日益增加，尤其是在竞争环境中的个体中，该领域正在获得关注。虽然神经调节享有成熟的临床验证，但认知增强正在迅速发展，受到技术整合和不断变化的消费者偏好的推动。这两个领域共同描绘了神经技术领域创新和机遇的动态图景。

### 按设备类型：侵入性设备（最大）与可穿戴设备（增长最快）

神经技术设备市场展示了多种设备类型，主要包括侵入式和可穿戴设备。由于在神经外科和深脑刺激中的应用成熟，侵入式设备占据了最大的市场份额。它们在治疗神经系统疾病方面的有效性和精确性巩固了它们的主导地位，而非侵入式设备虽然市场份额较小，但为寻求更少侵入性选择的患者提供了重要替代方案。可穿戴设备则代表了一个快速扩展的细分市场，因其在监测脑活动方面的便利性和功能性而受到消费者和医疗服务提供者的青睐。
神经技术设备市场的增长趋势受到技术进步和对个性化医疗解决方案需求增加的显著影响。侵入式设备在设计和功能上不断进步，导致改善的结果和患者满意度。同时，可穿戴设备因其与健康追踪应用和远程医疗的持续整合，吸引了年轻人和技术精明的消费者的关注。这种技术与医疗的融合为神经技术领域的创新和投资创造了良好的环境。

设备类型：侵入性设备（主导）与可穿戴设备（新兴）

侵入性设备长期以来被认为是神经技术的支柱，为复杂的神经系统疾病提供了针对性的治疗方法。它们在脑癌、运动障碍和癫痫管理等应用中的精确性凸显了它们在医疗实践中的重要性。另一方面，穿戴设备正在成为该领域的变革力量，提供可及的脑部监测和健康分析解决方案。随着消费者变得更加关注健康，这些设备使个人能够实时跟踪他们的神经健康，从而促进更大的参与和自我管理。侵入性设备的主导地位与穿戴技术的上升趋势之间的对比正在重塑神经技术的格局，这两个领域在推动治疗方法和患者结果方面都发挥着关键作用。

### 按最终用户：医院（最大）与康复中心（增长最快）

在神经技术设备市场中，医院占据了最大的市场份额，由于其先进的基础设施和多样化的患者需求，提供了可观的需求份额。这些机构利用神经技术设备进行广泛的应用，包括神经系统疾病的诊断、治疗和康复。医院在维持稳定市场份额方面的作用源于对医疗技术的持续投资以及对需要专业护理的神经系统疾病日益增长的流行。

另一方面，康复中心正在成为该市场中增长最快的细分市场。随着对神经康复在神经损伤后重要性的日益认可，这一增长得到了推动。随着越来越多的证据支持神经技术设备在促进康复方面的有效性，康复中心迅速采用这些技术以改善患者的治疗效果。向居家康复解决方案的转变也在推动这一细分市场的整体增长，使其成为神经技术设备领域的重要参与者。

医院（主导）与研究机构（新兴）

在神经技术设备市场中，医院因其丰富的资源和多样化的患者群体而主导该领域，这推动了对创新神经技术的需求。它们实施先进的神经成像和神经刺激设备，这些设备是现代医疗实践的核心。相比之下，研究机构虽然目前被归类为新兴领域，但在开发和测试尖端神经技术解决方案方面正变得越来越有影响力。这些机构在研究和开发中发挥着关键作用，为显著改善患者治疗方案的方法的进步做出贡献。研究机构与医院之间的合作促进了反馈循环，增强了研究成果的实际应用，从而为神经技术的创新发展铺平了道路。

### 按技术：脑电图（最大）与经颅磁刺激（增长最快）

在神经技术设备市场中，脑电图（EEG）以其显著的市场份额领先于该细分市场，这主要归因于其在诊断神经系统疾病和监测脑活动中的广泛应用。其非侵入性特征以及在研究和临床应用中的日益普及巩固了其地位。相反，跨颅磁刺激（TMS）在治疗抑郁症和其他心理健康状况中的新兴作用迅速获得关注，展现出在对非侵入性疗法需求日益增长的背景下显著的增长。

EEG（主导）与TMS（新兴）

脑电图（EEG）作为神经技术设备市场的主导技术，以其能够以最小的侵入性和高患者舒适度提供实时神经活动洞察而闻名。它广泛应用于各种临床应用，包括癫痫诊断和睡眠研究。另一方面，经颅磁刺激（TMS）作为一种变革性技术正在兴起，尤其是在治疗难治性抑郁症的精神治疗中越来越受到采用。其非侵入性的方法，加上技术和疗效的进步，使TMS在心理健康护理中成为一种有前景的解决方案。

## Regional Market Share Analysis

全球神经技术设备市场在各个地区展现出显著增长，北美在市场中占据主导地位，2023年市场价值为55亿美元，预计到2032年将达到145亿美元。这一优势得益于先进的医疗基础设施和对研发的重大投资。

欧洲紧随其后，成为第二大市场，2023年报告的市场价值为27亿美元，预计到2032年将增长至70亿美元，展现出神经技术解决方案的强大创新能力。亚太地区稳步崛起，2023年估值为18亿美元，预计增长至50亿美元，受益于日益增长的医疗需求和技术进步。

南美市场虽然较小，2023年为5亿美元，预计将扩展至15亿美元，随着对神经技术的认识增加，呈现出增长机会。中东和非洲（MEA）市场尚处于起步阶段，2023年市场价值为2.2亿美元，预计将达到8亿美元，突显出这些地区发展的潜力。

总体而言，全球神经技术设备市场的收入反映出一个多样化的市场格局，具有独特的区域动态和增长驱动因素。

来源：初步研究，二次研究，_市场研究未来_数据库及分析师评审

## Competitive Benchmarking

全球神经技术设备市场的特点是快速的技术进步和创新，这些进步和创新正在改变神经系统疾病和状况的治疗方式。

作为一个涵盖从神经刺激系统到脑机接口等多种设备的行业，竞争格局由既有的医疗设备制造商和新兴的初创公司共同构成。

市场参与者专注于战略合作、并购，以增强其产品供应并获得市场的显著份额。神经疾病和障碍的日益普遍，加上医疗专业人员对神经技术的日益关注，推动了对能够提供有效和创新解决方案的设备的需求。

因此，公司不断投资于研究和开发，以保持竞争优势，更有效地满足患者的需求。

Nervtech通过对创新和高质量产品开发的承诺，在全球神经技术设备市场中建立了强大的存在。该公司专注于先进的神经刺激设备，解决多种神经系统疾病，确立了其在这一快速发展的行业中的领导地位。

凭借坚实的研究基础，Nervtech因其强大的临床数据而受到好评，证明其设备的有效性和安全性。此外，该公司对用户体验和患者参与的关注也为其竞争优势做出了贡献，确保其产品不仅提供治疗益处，而且用户友好且易于获取。

这种技术实力与对患者需求的承诺相结合，使Nervtech能够在市场中保持强大的立足点，同时吸引医疗提供者和患者的关注。

Cynapsus Therapeutics明确专注于在全球神经技术设备市场中开发突破性解决方案，特别针对影响认知和心理健康的疾病。

该公司对神经技术的创新方法体现在其对基于研究的解决方案的承诺上，这些解决方案旨在满足患有神经系统疾病的患者的需求。Cynapsus Therapeutics强调其产品组合中明确有效性的必要性，展示旨在增强认知功能和改善患者生活质量的设备。

该组织积极与研究机构和临床医生合作，这增强了其市场存在感并巩固了其作为神经技术领域可靠参与者的声誉。此外，Cynapsus Therapeutics通过严格的临床试验和研究推动该领域的发展，展示了其作为神经技术解决方案未来关键贡献者的潜力。

## Recent News & Developments

- **2024年第二季度：Synchron宣布获得FDA批准进行首个美国脑-计算机接口植入临床试验** Synchron获得FDA批准，开始其Stentrode脑-计算机接口设备的首个美国临床试验，标志着神经科技植入物的重要监管里程碑。
- **2024年第二季度：Neuralink筹集4300万美元风险投资** 根据监管文件，埃隆·马斯克的Neuralink筹集了4300万美元的风险投资，以进一步开发其脑-计算机接口技术。
- **2024年第二季度：NeuroPace宣布获得FDA批准的下一代RNS系统用于癫痫治疗** NeuroPace获得FDA批准，其下一代响应性神经刺激（RNS）系统旨在治疗药物耐受性癫痫。
- **2024年第一季度：Blackrock Neurotech任命Marcus Gerhardt为首席执行官** Blackrock Neurotech宣布任命Marcus Gerhardt为首席执行官，标志着公司在推进其神经科技设备组合时的领导层变动。
- **2024年第二季度：Bioinduction宣布与美敦力合作推进深脑刺激疗法** Bioinduction与美敦力达成合作，共同开发和商业化下一代深脑刺激设备。
- **2024年第一季度：NeuroOne获得FDA 510(k)许可用于Evo sEEG电极** NeuroOne医疗技术公司获得FDA 510(k)许可，用于其Evo sEEG电极，扩展其微创脑监测设备的产品组合。
- **2024年第二季度：Synchron在加利福尼亚州开设新制造设施** Synchron宣布在加利福尼亚州开设新制造设施，以扩大其脑-计算机接口设备的生产规模。
- **2024年第一季度：Neuroelectrics完成1750万美元B轮融资以推进非侵入性脑刺激** Neuroelectrics完成了1750万美元的B轮融资，以加速其非侵入性脑刺激设备的开发和商业化。
- **2024年第二季度：Cala Health宣布获得FDA批准的下一代Cala kIQ设备用于治疗本质性震颤** Cala Health获得FDA批准，其下一代Cala kIQ设备是一种可穿戴的神经刺激设备，用于治疗本质性震颤。
- **2024年第一季度：NeuroSigma与大冢制药达成合作，在日本商业化Monarch eTNS系统** NeuroSigma与大冢制药达成合作，在日本商业化Monarch外部三叉神经刺激（eTNS）系统用于注意力缺陷多动障碍（ADHD）。
- **2024年第二季度：NeuroPace宣布获得6700万美元融资以支持商业扩展** NeuroPace获得6700万美元融资，以支持其癫痫治疗神经刺激设备的商业扩展。
- **2024年第一季度：Neurosoft Bioelectronics筹集800万美元种子资金以开发软脑植入物** Neurosoft Bioelectronics筹集了800万美元的种子资金，以推进其用于神经系统疾病的软性、灵活脑植入物的开发。

## Report Scope

| 2024年市场规模 | 132.7（十亿美元） |
| --- | --- |
| 2025年市场规模 | 147.7（十亿美元） |
| 2035年市场规模 | 428.9（十亿美元） |
| 复合年增长率（CAGR） | 11.25%（2024 - 2035） |
| 报告覆盖范围 | 收入预测、竞争格局、增长因素和趋势 |
| 基准年 | 2024 |
| 市场预测期 | 2025 - 2035 |
| 历史数据 | 2019 - 2024 |
| 市场预测单位 | 十亿美元 |
| 关键公司简介 | 市场分析进行中 |
| 覆盖的细分市场 | 市场细分分析进行中 |
| 关键市场机会 | 人工智能在神经技术设备市场的整合增强了个性化治疗选项和用户参与度。 |
| 关键市场动态 | 对先进神经技术设备的需求上升推动了关键市场参与者之间的创新和竞争。 |
| 覆盖的国家 | 北美、欧洲、亚太、南美、中东和非洲 |

## Frequently Asked Questions

**Q: 神经技术设备市场的当前估值是多少？**
A: 神经技术设备市场在2024年的估值为132.7亿美元。

**Q: 到2035年，神经技术设备市场的预计市场规模是多少？**
A: 预计到2035年，市场将达到428.9亿美元。

**Q: 在预测期内，神经技术设备市场的预期CAGR是多少？**
A: 神经技术设备市场在2025年至2035年期间的预期年复合增长率（CAGR）为11.25%。

**Q: 哪个应用领域预计将经历最高的增长？**
A: 神经调节细分市场预计将从2024年的39.9亿美元增长到2035年的125亿美元。

**Q: 神经技术设备市场的关键参与者有哪些？**
A: 主要参与者包括NeuroPace、Medtronic、Boston Scientific、Abbott等。

**Q: 侵入性设备和非侵入性设备在市场估值方面如何比较？**
A: 在2024年，侵入性设备的价值为26.5亿美元，而非侵入性设备的价值为40亿美元。

**Q: 神经技术设备市场中可穿戴设备的预计增长是多少？**
A: 可穿戴设备预计将从2024年的36.2亿美元增长到2035年的118.9亿美元。

**Q: 哪个终端用户细分市场预计将主导市场？**
A: 预计医院将在市场中占主导地位，从2024年的53.1亿美元增长到2035年的170亿美元。

**Q: 哪些技术正在推动神经技术设备市场的增长？**
A: 电生理学和功能性磁共振成像等技术正在推动增长，预计到2035年，分别将达到112亿美元和125亿美元的估值。

**Q: 神经技术设备市场的增长在不同细分市场之间如何比较？**
A: 市场在各个细分领域显示出不同的增长，预计认知增强将从2024年的20亿美元增长到2035年的65亿美元。


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/neurotech-device-market-33922*